ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

ONS Again Offers Nursing Certification Exam In May, Sept

January 11, 1991

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

March 13, 2009

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

“Withheld” News Release On QRA Policies Released

November 11, 1983